Ironwood Pharmaceuticals annual gross profit
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Ironwood Pharmaceuticals Gross Profit Growth & History (IRWD)
Ironwood Pharmaceuticals's gross profit was $410.6M for fiscal 2022.
View full Ironwood Pharmaceuticals company overviewIronwood Pharmaceuticals annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $410.6M | −$3.2M | −0.76% |
| 2021 | 2021-12-31 | $413.8M | $27.4M | +7.08% |
| 2020 | 2020-12-31 | $386.4M | −$18.2M | −4.49% |
| 2019 | 2019-12-31 | $404.5M | $90.7M | +28.88% |
| 2018 | 2018-12-31 | $313.9M | $34.7M | +12.43% |
| 2017 | 2017-12-31 | $279.2M | $7.1M | +2.61% |
| 2016 | 2016-12-31 | $272.1M | $122.5M | +81.95% |
| 2015 | 2015-12-31 | $149.5M | $78.4M | +110.19% |
| 2014 | 2014-12-31 | $71.1M | $55.5M | +353.79% |
| 2013 | 2013-12-31 | $15.7M | −$133.6M | −89.50% |
| 2012 | 2012-12-31 | $149.3M | — | — |
Ironwood Pharmaceuticals quarterly gross profit
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q1.15
Q2.15
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q4 2020 | 2020-12-31 | $115.8M | $495,000 | +0.43% |
| Q3 2020 | 2020-09-30 | $103.5M | −$27.2M | −20.81% |
| Q2 2020 | 2020-06-30 | $89.4M | −$1.5M | −1.62% |
| Q1 2020 | 2020-03-31 | $77.7M | $10.0M | +14.80% |
| Q4 2019 | 2019-12-31 | $115.3M | $6.1M | +5.55% |
| Q3 2019 | 2019-09-30 | $130.7M | $69.6M | +113.95% |
| Q2 2019 | 2019-06-30 | $90.9M | $13.9M | +17.99% |
| Q1 2019 | 2019-03-31 | $67.7M | $1.1M | +1.71% |
| Q4 2018 | 2018-12-31 | $109.2M | $24.0M | +28.17% |
| Q3 2018 | 2018-09-30 | $61.1M | −$19.7M | −24.37% |
| Q2 2018 | 2018-06-30 | $77.0M | $15.5M | +25.12% |
| Q1 2018 | 2018-03-31 | $66.5M | $14.9M | +28.88% |
| Q4 2017 | 2017-12-31 | $85.2M | — | — |
| Q3 2017 | 2017-09-30 | $80.7M | — | — |
| Q2 2017 | 2017-06-30 | $61.6M | — | — |
| Q1 2017 | 2017-03-31 | $51.6M | — | — |
| Q2 2015 | 2015-06-30 | $19.6M | $23.3M | — |
| Q1 2015 | 2015-03-31 | $28.9M | $16.2M | +128.06% |
| Q2 2014 | 2014-06-30 | −$3.7M | −$9.9M | — |
| Q1 2014 | 2014-03-31 | $12.7M | $10.7M | +526.53% |
| Q4 2013 | 2013-12-31 | $4.5M | — | — |
| Q3 2013 | 2013-09-30 | $2.9M | — | — |
| Q2 2013 | 2013-06-30 | $6.2M | — | — |
| Q1 2013 | 2013-03-31 | $2.0M | — | — |
Ironwood Pharmaceuticals gross profit trends
Over the last five fiscal years, Ironwood Pharmaceuticals's gross profit increased from $279.2M to $410.6M, a change of $131.4M. The latest reported quarter, Q4 2020, shows $115.8M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ironwood Pharmaceuticals source filings ↗